AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Tharimmune, Inc. Director's Dealing 2022

Jun 7, 2022

Director's Dealing

Opens in your device viewer

Issuer: Hillstream BioPharma Inc. (HILS)
CIK: 0001861657
Period of Report: 2022-06-06

Reporting Person: MILBY RANDY (Director, Chief Executive Officer)

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-06-06	Common Stock	P	234	$0.6849	Acquired	2937774	Direct
2022-06-06	Common Stock	P	100	$0.6701	Acquired	2937874	Direct
2022-06-06	Common Stock	P	100	$0.6701	Acquired	2937974	Direct
2022-06-06	Common Stock	P	66	$0.6701	Acquired	2938040	Direct
2022-06-06	Common Stock	P	500	$0.6999	Acquired	2938540	Direct